Logo image of WEED.CA

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

TSX:WEED - Toronto Stock Exchange - CA1380357048 - Common Stock - Currency: CAD

2.31  +0.04 (+1.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to WEED. WEED was compared to 34 industry peers in the Pharmaceuticals industry. The financial health of WEED is average, but there are quite some concerns on its profitability. WEED has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WEED has reported negative net income.
WEED had a negative operating cash flow in the past year.
WEED had negative earnings in each of the past 5 years.
In the past 5 years WEED always reported negative operating cash flow.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1B -2B -3B

1.2 Ratios

WEED's Return On Assets of -40.34% is on the low side compared to the rest of the industry. WEED is outperformed by 78.79% of its industry peers.
With a Return On Equity value of -79.41%, WEED is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -40.34%
ROE -79.41%
ROIC N/A
ROA(3y)-63.49%
ROA(5y)-47.06%
ROE(3y)-181.56%
ROE(5y)-123.98%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

WEED has a Gross Margin (30.40%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of WEED has grown nicely.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y29.93%
GM growth 5Y16.63%
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

5

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEED has less shares outstanding
WEED has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, WEED has an improved debt to assets ratio.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -9.78, we must say that WEED is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WEED (-9.78) is worse than 84.85% of its industry peers.
A Debt/Equity ratio of 0.79 indicates that WEED is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.79, WEED is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z -9.78
ROIC/WACCN/A
WACC9.27%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

WEED has a Current Ratio of 3.52. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of WEED (3.52) is better than 90.91% of its industry peers.
WEED has a Quick Ratio of 2.58. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
WEED has a better Quick ratio (2.58) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 2.58
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.54% over the past year.
WEED shows a decrease in Revenue. In the last year, the revenue decreased by -7.16%.
WEED shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.60% yearly.
EPS 1Y (TTM)74.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.43%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-18.39%
Revenue growth 5Y5.6%
Sales Q2Q%-2.44%

3.2 Future

The Earnings Per Share is expected to grow by 14.00% on average over the next years. This is quite good.
WEED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.09% yearly.
EPS Next Y50.24%
EPS Next 2Y38.86%
EPS Next 3Y24.86%
EPS Next 5Y14%
Revenue Next Year-16.64%
Revenue Next 2Y-5.38%
Revenue Next 3Y-1.49%
Revenue Next 5Y3.09%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEED. In the last year negative earnings were reported.
Also next year WEED is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

WEED's earnings are expected to grow with 24.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.86%
EPS Next 3Y24.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WEED!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANOPY GROWTH CORP

TSX:WEED (2/21/2025, 7:00:00 PM)

2.31

+0.04 (+1.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-07 2025-02-07/bmo
Earnings (Next)05-30 2025-05-30/amc
Inst Owners6.95%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap400.51M
Analysts47.06
Price Target3.91 (69.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-164.26%
Min EPS beat(2)-231.12%
Max EPS beat(2)-97.39%
EPS beat(4)0
Avg EPS beat(4)-173.54%
Min EPS beat(4)-240.27%
Max EPS beat(4)-97.39%
EPS beat(8)1
Avg EPS beat(8)-220.15%
EPS beat(12)1
Avg EPS beat(12)-210.2%
EPS beat(16)4
Avg EPS beat(16)-163.89%
Revenue beat(2)1
Avg Revenue beat(2)4.18%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)8.65%
Revenue beat(4)2
Avg Revenue beat(4)3.25%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)12.74%
Revenue beat(8)4
Avg Revenue beat(8)2.69%
Revenue beat(12)5
Avg Revenue beat(12)-1.83%
Revenue beat(16)6
Avg Revenue beat(16)-2.69%
PT rev (1m)-36.7%
PT rev (3m)-44.04%
EPS NQ rev (1m)-3.58%
EPS NQ rev (3m)-89.34%
EPS NY rev (1m)-25.61%
EPS NY rev (3m)-72.74%
Revenue NQ rev (1m)3.39%
Revenue NQ rev (3m)-5.67%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-5.2
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.94
FCFYN/A
OCF(TTM)-0.89
OCFYN/A
SpS1.6
BVpS3.41
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.34%
ROE -79.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.4%
FCFM N/A
ROA(3y)-63.49%
ROA(5y)-47.06%
ROE(3y)-181.56%
ROE(5y)-123.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y29.93%
GM growth 5Y16.63%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.12%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.52
Quick Ratio 2.58
Altman-Z -9.78
F-Score6
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)20.68%
Cap/Depr(5y)155.29%
Cap/Sales(3y)4.46%
Cap/Sales(5y)45.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.43%
EPS Next Y50.24%
EPS Next 2Y38.86%
EPS Next 3Y24.86%
EPS Next 5Y14%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-18.39%
Revenue growth 5Y5.6%
Sales Q2Q%-2.44%
Revenue Next Year-16.64%
Revenue Next 2Y-5.38%
Revenue Next 3Y-1.49%
Revenue Next 5Y3.09%
EBIT growth 1Y64.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.93%
EBIT Next 3Y27.27%
EBIT Next 5Y16.78%
FCF growth 1Y70.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.6%
OCF growth 3YN/A
OCF growth 5YN/A